Healthcare
Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials
DETROIT, July 17, 2026--Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves.
About this update from Bayer Ag
Henry Ford Health selected as one of only four U.S. academic health systems in Bayer's strategic research network DETROIT, July 17, 2026 --( BUSINESS WIRE )--Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer's global drug development expertise with Henry Ford Health's comprehensive clinical research program and its deep connection to the communities it serves. "Clinical trials are often the first opportunity patients have to access cutting-edge treatments," said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. "Through this collaboration, we aim to make clinical research more accessible, reduce barriers to participation, accelerate the development of new treatments and ensure that more patients have the opportunity to benefit from medical innovation." Initial efforts will focus on several key areas that align with Bayer's growing pipeline and product offerings: Together, the organizations will collaboratively work across the full clinical trial process, using data and technology to design smarter trials. Patients will be able to access novel treatments sooner by reducing barriers to participation. "Bayer is consistently exploring new avenues that can help more patients with diseases or health conditions that impact millions of people across the world," said Christoph Koenen, Head, Clinical Development & Operations for Bayer. "We share this commitment to patients and advancing drug discovery with likeminded institutions like Henry Ford Health that can help reduce barriers to accessing investigational or potential new treatments right in the very communities where patients are already receiving their care." The partnership will add more areas of medicinal research as time goes on. Beyond clinical trials, the organizations plan to work together in areas such as: The partnership reflects a shared commitment to advancing clinical research in ways that are faster, more inclusive, and more accessible for patients.